Suppr超能文献

2018 - 2021年国家乳腺癌和宫颈癌早期检测项目的资格条件及覆盖范围

Eligibility for and reach of the National Breast and Cervical Cancer Early Detection Program, 2018-2021.

作者信息

Tangka Florence K L, Kenney Kristy, Miller Jacqueline, Howard David H

机构信息

Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Department of Health Policy and Management, Winship Cancer Center, Emory University, 1518 Clifton Road NE, Atlanta, GA, 30030, USA.

出版信息

Cancer Causes Control. 2025 May;36(5):531-538. doi: 10.1007/s10552-024-01947-4. Epub 2025 Jan 8.

Abstract

PURPOSE

The National Breast and Cervical Cancer Early Detection Program (NBCCEDP) provides access to timely breast and cervical cancer screening and diagnostic services to women who have low incomes and are uninsured or underinsured. Documenting the number of women eligible and the proportion of eligible women who receive NBCCEDP-funded services is important for identifying opportunities to increase screening and diagnostic services among those who would not otherwise have access.

METHODS

Using the Census Bureau's Small Area Health Insurance Estimates data, we estimated the number of women who met the NBCCEDP eligibility criteria based on age, income, and insurance status. We used these estimates along with the number of women served by the NBCCEDP to calculate the percent of women served by race/ethnicity and state. We calculated the percent of eligible women who are up to date with screening using the 2019 National Health Interview Survey.

RESULTS

The NBCCEDP served 15.0% of women ages 40-64 eligible for breast cancer services in 2018-2019 and 5.6% of women ages 21-64 eligible for cervical cancer services in 2018-2020. The NBCCEDP served 13.5% of women ages 40-64 eligible for breast cancer services in 2020-2021 and 5.9% of women ages 21-64 eligible for cervical cancer services in 2019-2021. The percent of women ages 40-64 who received breast cancer services declined by 1.5 percentage points between 2018-2019 and 2020-2021. The percent of women ages 21-64 who received cervical cancer services increased by 0.3 percentage points between 2018-2020 and 2019-2021. The percent of eligible women served varied among states. The state interquartile ranges of the percent of women served were 12.3-27.7% for breast cancer services in 2018-2019 and 3.9-14.7% for cervical cancer services in 2018-2020. Among women eligible for the NBCCEDP, 61.4% are not up to date with breast cancer screening and 40.6% are not up to date with cervical cancer screening.

CONCLUSION

There is wide variation between states in the share of eligible women served for breast and cervical cancer screening services. We found that both the number and the percentage of eligible women who received NBCCEDP breast cancer services declined during a period that overlapped with the COVID-19 pandemic. A large proportion of eligible women did not receive breast or cervical cancer screening.

摘要

目的

国家乳腺癌和宫颈癌早期检测项目(NBCCEDP)为低收入且未参保或保险不足的女性提供及时的乳腺癌和宫颈癌筛查及诊断服务。记录符合条件的女性数量以及接受NBCCEDP资助服务的符合条件女性的比例,对于确定在那些原本无法获得服务的人群中增加筛查和诊断服务的机会非常重要。

方法

利用人口普查局的小区域健康保险估计数据,我们根据年龄、收入和保险状况估算了符合NBCCEDP资格标准的女性数量。我们将这些估计值与NBCCEDP服务的女性数量相结合,按种族/族裔和州计算接受服务的女性百分比。我们使用2019年国家健康访谈调查来计算符合条件且筛查及时的女性百分比。

结果

2018 - 2019年,NBCCEDP为40 - 64岁符合乳腺癌服务条件的女性中的15.0%提供了服务,2018 - 2020年为21 - 64岁符合宫颈癌服务条件的女性中的5.6%提供了服务。2020 - 2021年,NBCCEDP为40 - 64岁符合乳腺癌服务条件的女性中的13.5%提供了服务,2019 - 2021年为21 - 64岁符合宫颈癌服务条件的女性中的5.9%提供了服务。2018 - 2019年至2020 - 2021年期间,40 - 64岁接受乳腺癌服务的女性百分比下降了1.5个百分点。2018 - 2020年至2019 - 2021年期间,21 - 64岁接受宫颈癌服务的女性百分比增加了0.3个百分点。接受服务的符合条件女性百分比在各州之间存在差异。2018 - 2019年乳腺癌服务的女性百分比的州四分位距为12.3% - 27.7%,2018 - 2020年宫颈癌服务的为3.9% - 14.7%。在符合NBCCEDP条件的女性中,61.4%的人乳腺癌筛查不及时,40.6%的人宫颈癌筛查不及时。

结论

各州在接受乳腺癌和宫颈癌筛查服务的符合条件女性比例方面存在很大差异。我们发现,在与COVID - 19大流行重叠的时期,接受NBCCEDP乳腺癌服务的符合条件女性的数量和百分比均有所下降。很大一部分符合条件的女性没有接受乳腺癌或宫颈癌筛查。

相似文献

本文引用的文献

2
Changes In Health Coverage During The COVID-19 Pandemic.新冠肺炎大流行期间的医保覆盖变化。
Health Aff (Millwood). 2023 May;42(5):721-726. doi: 10.1377/hlthaff.2022.01469.
3
Impact of the COVID-19 Pandemic on Cancer Screening Delays.COVID-19 大流行对癌症筛查延误的影响。
J Clin Oncol. 2023 Jun 10;41(17):3194-3202. doi: 10.1200/JCO.22.01704. Epub 2023 Feb 3.
8
Cancer Screening Test Use-U.S., 2019.癌症筛查测试的使用情况-美国,2019 年。
Am J Prev Med. 2022 Sep;63(3):431-439. doi: 10.1016/j.amepre.2022.02.018. Epub 2022 Apr 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验